comprehensive -WSS

comprehensive

author：knowledge 2025-09-06 03:17:30 - browse：15867

A view of different flags of the European Union Members. -- first opinion coverage from STAT — Ronald Wittek, Pool Photo via AP

Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma companies to efficiently launch products in multiple countries and contributing to the disparities in access across the continent.

But change is on the horizon: In less than 15 months, the European Union will establish and begin to implement a standardized, pan-EU framework, which all 27 of member states will be required to use to assess the clinical evidence of newly submitted products or devices. A key pillar of the EU’s Regulation on Health Technology Assessment (HTA), the Joint Clinical Assessment (JCA) aims to establish a single, transparent process to reduce redundant practices and bring life science innovation faster to patients in Europe — no matter where they live.

In a longstanding problem in Europe, access to — and the availability of — medication varies across the member states. For example, in Germany, 87% of products approved by the European Medicines Agency (EMA) have full availability (the product gained access on the public reimbursement list without any restrictions to the patient population). In Poland, that figure drops to 8%, according to a report published by the European Federation of Pharmaceutical Industries. Meanwhile, there is a tremendous difference in the gap between an oncology therapy receiving marketing authorization and a formal positive reimbursement decision, ranging from an average of 86 days in Denmark to 981 days in Latvia.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： National associations that represent hospice owe an apology

WSS

Medicare drug price lawsuits could be good politics for Biden

Future doctors need a strong humanities education

Study: Spinal cord stimulation helps patients with paralysis walk again

The inclusion problem at the heart of rehabilitation research

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

How the drug

explore

comprehensive

focus

At least 13 dead in Texas as scorching temps continue

TikTok, Instagram influencers need more rules for drug ads

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

High breast density mammograms need follow

George Santos makes 1st court appearance after pleading not guilty to 13 counts

HPV vaccine, cervical cancer study delivers historic results

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Trans patients at the end of life deserve respect and dignity

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Study: Spinal cord stimulation helps patients with paralysis walk again

explore

PBMs are inflating the cost of generic drugs. They must be reined in

Update the Apgar Score to remove skin color

The inclusion problem at the heart of rehabilitation research

Head of FDA's diagnostics center, who led through Covid, retires

Vivek Ramaswamy made waves in the debate, much as in biotech

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

explore

leisure time

Wikipedia

hotspot